Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02922894 · ClinicalTrials.gov registry record · Phase 4

Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury

A Phase 4 study of Spinal Cord Injury and Sleep Apnea, sponsored by John D. Dingell VA Medical Center.

Recruiting
Registry status
Phase 4
Development phase
100
Enrollment target
1
Study location

NCT02922894: Recruiting Phase 4 study of Spinal Cord Injury and Sleep Apnea, sponsored by John D. Dingell VA Medical Center.

NCT02922894 is a Phase 4 study of Spinal Cord Injury and Sleep Apnea that is actively recruiting participants, run by John D. Dingell VA Medical Center. The registered enrollment target is 100 participants, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02922894, a Phase 4 study of Spinal Cord Injury and Sleep Apnea, is actively recruiting participants, sponsored by John D. Dingell VA Medical Center.

RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study will investigate potential therapeutic approaches for sleep-disordered breathing (SDB) in patients with chronic cervical spine injury (\>6 months post-injury).

Primary Outcome

Change in tidal volume from baseline to recovery period.

Conditions Studied

Spinal Cord Injury Sleep Apnea

Interventions

  • DRUG Placebo
  • DRUG Trazodone
  • PROCEDURE Acute episodic hypoxia
  • PROCEDURE Supplemental oxygen
  • PROCEDURE Sham

Study Locations (1)

Michigan

  • John D. Dingell VA Medical Center - Detroit

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-06-09
Est. Completion 2026-06-30
Phase Phase 4
John D. Dingell VA Medical Center

1 total trials

What NCT02922894 shows while recruiting

NCT02922894 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (18% higher).

The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.

NCT02922894 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02922894 about?

NCT02922894 is a clinical study titled "Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury". This study will investigate potential therapeutic approaches for sleep-disordered breathing (SDB) in patients with chronic cervical spine injury (\>6 months post-injury).

What is the current status of trial NCT02922894?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2017-06-09. Estimated completion is 2026-06-30.

What conditions does trial NCT02922894 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Sleep Apnea.

What interventions are being tested in trial NCT02922894?

The interventions under investigation include: Placebo (DRUG), Trazodone (DRUG), Acute episodic hypoxia (PROCEDURE), Supplemental oxygen (PROCEDURE), Sham (PROCEDURE).

Who is sponsoring clinical trial NCT02922894?

This trial is sponsored by John D. Dingell VA Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02922894 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02922894's enrollment target sits among peer trials

100 16th of 99 higher than 82 of 99 other Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT02922894

Source: ClinicalTrials.gov NCT02922894, the US trial registry maintained by the National Library of Medicine. NCT02922894 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.